Harris Isbell

4.7k total citations · 1 hit paper
63 papers, 2.8k citations indexed

About

Harris Isbell is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Harris Isbell has authored 63 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Clinical Psychology, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Pharmacology. Recurrent topics in Harris Isbell's work include Psychedelics and Drug Studies (11 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Forensic Toxicology and Drug Analysis (8 papers). Harris Isbell is often cited by papers focused on Psychedelics and Drug Studies (11 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Forensic Toxicology and Drug Analysis (8 papers). Harris Isbell collaborates with scholars based in United States, Bulgaria and Switzerland. Harris Isbell's co-authors include H. F. Fraser, Abraham Wikler, E. J. Miner, A. B. Wolbach, Donald R. Jasinski, Anna J. Eisenman, Richard E. Belleville, H Halbach, Gabriele Horn and F. Körte and has published in prestigious journals such as JAMA, Annals of Internal Medicine and American Journal of Psychiatry.

In The Last Decade

Harris Isbell

60 papers receiving 2.3k citations

Hit Papers

An Experimental Study of the Etiology of “Rum Fits” and D... 1955 2026 1978 2002 1955 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harris Isbell United States 28 1.1k 784 656 318 289 63 2.8k
Abraham Wikler United States 32 2.1k 1.8× 494 0.6× 432 0.7× 633 2.0× 619 2.1× 93 4.1k
H. F. Fraser United States 23 642 0.6× 159 0.2× 258 0.4× 325 1.0× 346 1.2× 50 1.8k
Charles A. Haertzen United States 27 1.2k 1.0× 710 0.9× 396 0.6× 453 1.4× 274 0.9× 78 2.8k
Jerome H. Jaffe United States 43 1.9k 1.7× 587 0.7× 839 1.3× 1.2k 3.8× 475 1.6× 166 6.0k
M.H. SEEVERS United States 16 929 0.8× 172 0.2× 290 0.4× 293 0.9× 368 1.3× 25 1.5k
Berta Lasheras Spain 28 995 0.9× 296 0.4× 457 0.7× 563 1.8× 318 1.1× 73 2.8k
Morris A. Lipton United States 30 2.0k 1.7× 214 0.3× 571 0.9× 1.2k 3.7× 468 1.6× 68 3.9k
Iain M. McIntyre United States 35 574 0.5× 554 0.7× 580 0.9× 304 1.0× 249 0.9× 137 3.5k
Ralph A. O’Connell United States 16 1.3k 1.1× 584 0.7× 418 0.6× 663 2.1× 202 0.7× 32 3.4k
Robert Byck United States 23 690 0.6× 169 0.2× 385 0.6× 311 1.0× 174 0.6× 49 2.0k

Countries citing papers authored by Harris Isbell

Since Specialization
Citations

This map shows the geographic impact of Harris Isbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harris Isbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harris Isbell more than expected).

Fields of papers citing papers by Harris Isbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harris Isbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harris Isbell. The network helps show where Harris Isbell may publish in the future.

Co-authorship network of co-authors of Harris Isbell

This figure shows the co-authorship network connecting the top 25 collaborators of Harris Isbell. A scholar is included among the top collaborators of Harris Isbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harris Isbell. Harris Isbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isbell, Harris. (1971). Clinical Aspects of the Various Forms of Nonmedical Use of Drugs Part II. Anesthesia & Analgesia. 50(6). 897–905. 3 indexed citations
2.
Isbell, Harris. (1971). Clinical Aspects of the Various Forms of Nonmedical Use of Drugs Part I. Anesthesia & Analgesia. 50(5). 886–896. 4 indexed citations
3.
Isbell, Harris & Donald R. Jasinski. (1969). A comparison of LSD-25 with (?)-?9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC. Psychopharmacology. 14(2). 115–123. 64 indexed citations
4.
Isbell, Harris, et al.. (1967). Effects of (?)?9-trans-tetrahydrocannabinol in man. Psychopharmacology. 11(2). 184–188. 309 indexed citations
5.
Wolbach, A. B., Harris Isbell, & E. J. Miner. (1962). Cross tolerance between mescaline and LSD-25 with a comparison of the mescaline and LSD reactions. Psychopharmacology. 3(1). 1–14. 83 indexed citations
6.
Fraser, H. F., Gabriele Horn, W R Martin, A. B. Wolbach, & Harris Isbell. (1961). METHODS FOR EVALUATING ADDICTION LIABILITY. (A) "ATTITUDE" OF OPIATE ADDICTS TOWARD OPIATE-LIKE DRUGS, (B) A SHORT-TERM "DIRECT" ADDICTION TEST. Journal of Pharmacology and Experimental Therapeutics. 133(3). 371–387. 193 indexed citations
7.
Isbell, Harris. (1960). The pharmacology of the opiates and similar addiction-producing drugs.. PubMed. 53. 925–6. 2 indexed citations
8.
Fraser, H. F., Harris Isbell, & Gabriele Horn. (1960). HUMAN PHARMACOLOGY AND ADDICTION LIABILITY OF NORCODEINE. Journal of Pharmacology and Experimental Therapeutics. 129(2). 172–177. 14 indexed citations
9.
Eddy, Nathan B. & Harris Isbell. (1959). Addiction Liability and Narcotics Control. Public Health Reports (1896-1970). 74(9). 755–755. 3 indexed citations
10.
Isbell, Harris, et al.. (1959). Cross tolerance between d-2-brom-lysergic acid diethylamide (BOL-148) and the d-diethylamide of lysergic acid (LSD-25). Psychopharmacology. 1(2). 109–116. 14 indexed citations
11.
Fraser, H. F., Abraham Wikler, Gabriele Horn, Anna J. Eisenman, & Harris Isbell. (1958). HUMAN PHARMACOLOGY AND ADDICTION LIABILITY OF NORMORPHINE. Journal of Pharmacology and Experimental Therapeutics. 122(3). 359–369. 4 indexed citations
12.
Isbell, Harris. (1956). THE SEARCH FOR A NONADDICTING ANALGESIC. Journal of the American Medical Association. 161(13). 1254–1254. 4 indexed citations
13.
Jellinek, E. M., et al.. (1955). The “Craving” for Alcohol; A Symposium by Members of the WHO Expert Committees on Mental Health and on Alcohol. Quarterly Journal of Studies on Alcohol. 16(1). 34–66. 42 indexed citations
14.
Isbell, Harris. (1955). Medical aspects of opiate addiction.. PubMed. 31(12). 886–901. 9 indexed citations
15.
Wikler, Abraham, H. F. Fraser, Harris Isbell, & Frank T. Pescor. (1955). Electroencephalograms during cycles of addiction to barbiturates in man. Electroencephalography and Clinical Neurophysiology. 7(1). 1–13. 26 indexed citations
16.
Isbell, Harris, et al.. (1954). Use of miotic effect in evaluating analgesic drugs in man.. PubMed. 98(4). 443–51. 30 indexed citations
17.
Fraser, H. F. & Harris Isbell. (1954). ABSTINENCE SYNDROME IN DOGS AFTER CHRONIC BARBITURATE MEDICATION. Journal of Pharmacology and Experimental Therapeutics. 112(3). 261–267. 22 indexed citations
18.
Wikler, Abraham, H. F. Fraser, & Harris Isbell. (1953). N-ALLYLNORMORPHINE: EFFECTS OF SINGLE DOSES AND PRECIPITATION OF ACUTE "ABSTINENCE SYNDROMES" DURING ADDICTION TO MORPHINE, METHADONE OR HEROIN IN MAN (POST-ADDICTS). Journal of Pharmacology and Experimental Therapeutics. 109(1). 8–20. 126 indexed citations
19.
Fraser, H. F. & Harris Isbell. (1953). FAILURE OF CORTISONE AND ACTH IN TREATMENT OF THE MORPHINE ABSTINENCE SYNDROME. Annals of Internal Medicine. 38(2). 234–238. 5 indexed citations
20.
Isbell, Harris & H. F. Fraser. (1953). ACTIONS AND ADDICTION LIABILITIES OF DROMORAN DERIVATIVES IN MAN. Journal of Pharmacology and Experimental Therapeutics. 107(4). 524–530. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026